(Rac) -Etavopivat
Etavopivat (FT-4202) is an orally bioavailable, small-molecule activator of red blood cell pyruvate kinase (PKR) . It is investigated in preclinical and clinical research for the treatment of sickle cell disease and other hemoglobinopathies, with studies demonstrating its potential to improve erythrocyte health and function.
Product Specifications
CAS Number
2622070-93-1
Field of Research
Metabolism Research, Signal Transduction
Smiles
S (=O) (=O) (N1CC2=C (C1) CN (C (C (CO) C3=CC=CC=C3) =O) C2) C=4C=C5C (=NC4) OCCO5
Molecular Formula
C22H23N3O6S
Molecular Weight
457.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
354850-01 48 Tests
CML (Carboxymethyl Lysine) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 354850-02 96 Tests
CML (Carboxymethyl Lysine) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 
MBS2120095-01 0.1 mL
APC-Linked Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details MBS2120095-02 0.2 mL
APC-Linked Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details MBS2120095-03 0.5 mL
APC-Linked Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details MBS2120095-04 1 mL
APC-Linked Polyclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details